Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal
Status:
Completed
Trial end date:
2015-07-15
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study on the
effectiveness of treatment with beta-blockers to prevent decompensation of cirrhosis with
portal hypertension.
Phase:
Phase 4
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau